Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4436
Gene Symbol: MSH2
MSH2
0.140 GeneticVariation disease BEFREE We diagnosed her with Muir-Torre syndrome based on the following evidence: 1) high prevalence of microsatellite instability in gene locus assay, 2) absence of mismatch repair proteins in the sebaceous carcinoma on immunohistochemical analysis, and 3) a genetic mutation of 1226_1227delAG in the MSH2 exon 7 in the lesion detected by DNA sequencing analysis. 31664942 2019
Entrez Id: 4436
Gene Symbol: MSH2
MSH2
0.140 Biomarker disease BEFREE LS was suspected due to a positive family history of CRC and because of MSI-H and MSH2-MSH6 deficiency on IHC in the sebaceous gland carcinoma. 24518836 2014
Entrez Id: 4436
Gene Symbol: MSH2
MSH2
0.140 AlteredExpression disease BEFREE The finding of deficient MSH2 expression in the immunohistochemical analysis of a sebaceous carcinoma prompted genetic testing for a systemic mutation in the mismatch repair gene. 21550136 2011
Entrez Id: 4436
Gene Symbol: MSH2
MSH2
0.140 AlteredExpression disease BEFREE Immunohistochemical analysis showed diminished MSH2 protein levels in the sebaceous carcinoma and colonic adenocarcinoma. 17941949 2008
Entrez Id: 4436
Gene Symbol: MSH2
MSH2
0.140 Biomarker disease HPO
Entrez Id: 4292
Gene Symbol: MLH1
MLH1
0.100 Biomarker disease HPO
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.070 AlteredExpression disease BEFREE To determine the role of p53 and its downstream target gene sestrin2 expression and p53 gene mutation status in SGC. 29478030 2018
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.070 GeneticVariation disease BEFREE TP53 and RB1 mutations were restricted to ocular SC and correlated with aberrant TP53 and RB protein expression. 27287813 2016
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.070 GeneticVariation disease BEFREE Retrospective case series.Fourteen samples of sebaceous carcinoma that had been resected from Caucasian patients between 1994 and 2010 were analyzed for p53 gene mutations with PCR and Sequencher software. 24777261 2015
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.070 Biomarker disease BEFREE Tumors with strong nuclear p53 staining were significantly associated with the diagnosis of sebaceous carcinoma compared with benign sebaceous lesions, most notably for periocular carcinomas. 22441365 2012
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.070 Biomarker disease BEFREE A detailed histopathological study including p53 DNA sequencing was performed on an aggressive sebaceous carcinoma presenting in a healthy 32 year-old Caucasian woman. 21892948 2011
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.070 AlteredExpression disease BEFREE Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. 19628749 2010
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.070 PosttranslationalModification disease BEFREE Mutational inactivation of p53 may be involved in the progression of sebaceous carcinoma. 9499782 1998
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.030 Biomarker disease BEFREE In this study, we aim to characterize the expression pattern of PD-1 and its ligands PD-L1 and PD-L2 in both sebaceous carcinoma and in infiltrating immune cells to explore the potential use of checkpoint blockade as therapy. 31593039 2020
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.030 AlteredExpression disease BEFREE Patient clinical characteristics and PD-L1 expression related to SC prognostic values were evaluated. 29862664 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.030 AlteredExpression disease BEFREE High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma. 30228943 2018
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.030 Biomarker disease BEFREE Strong immunohistochemical p16 positivity (meeting the criterion of >70% nuclear and cytoplasmic staining) was present in 29 of 35 cases of periocular SC (82.9%). 27457256 2016
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.030 AlteredExpression disease BEFREE Furthermore, p16 overexpression in eyelid SCs was also significantly higher than that in other eyelid tumors. 25468813 2015
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.030 AlteredExpression disease BEFREE In order to clarify and explore the molecular and epigenetic basis of HPV, CDKN2A status and role of microsatellite instability in the development of periocular sebaceous carcinoma, 24 cases of periocular sebaceous carcinoma were analyzed for the expression of p16(INK4a) and mismatch repair proteins (MLH1, MSH2, MSH6 and PMS2) via immunohistochemistry. 24440092 2014
Entrez Id: 123
Gene Symbol: PLIN2
PLIN2
0.020 Biomarker disease BEFREE Immunohistochemical markers informing the diagnosis of sebaceous carcinoma and its distinction from its mimics: Adipophilin and factor XIIIa to the rescue? 29087003 2018
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.020 GeneticVariation disease BEFREE Because we recently demonstrated absence of KRAS mutations in Korean eyelid SCs, we extended our previous study to the analysis of NRAS, BRAF, PIK3CA, and CTNNB1 mutations, and the examination of related protein expressions in 15 eyelid SCs. 28551389 2017
Entrez Id: 123
Gene Symbol: PLIN2
PLIN2
0.020 Biomarker disease BEFREE Comparison of antibodies used for immunohistochemical diagnosis of sebaceous carcinoma (SC) suggests that adipophilin has the highest sensitivity and specificity. 28256768 2017
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.020 Biomarker disease BEFREE Strong immunohistochemical p16 positivity (meeting the criterion of >70% nuclear and cytoplasmic staining) was present in 29 of 35 cases of periocular SC (82.9%). 27457256 2016
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.020 Biomarker disease BEFREE HER2 protein overexpression and HER2 amplification were found more frequently in eyelid SCs than in other eyelid tumors.All SCs harbored wild type KRAS genes. 25468813 2015
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.020 AlteredExpression disease BEFREE Furthermore, p16 overexpression in eyelid SCs was also significantly higher than that in other eyelid tumors. 25468813 2015